Drugs / DHEA
last change Dec 2014 re-read 3 minutes ago

DHEA

Developed for
vaginal disorder
Investigated by
Hadassah Medical Organization

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT01724242 Feb 2013 → Jan 2014 breast cancer, vaginal disorder Hadassah Medical Organization Withdrawn No outcome recorded Stop: Enrollment

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DHEA ClinicalTrials.gov intervention name — accepted as the source's own label NCT01724242 ↗
Route Other “Vaginal DHEA 0.5%(6.5mg)inserted nightly” NCT01724242 ↗